2nd ANNUAL BARBADOS MEDICAL CANNABIS CONFERENCE
February 22nd and 23rd, 2020 at the University of the West Indies, Cave Hill, Barbados
US CANNABIS Pharmaceutical Research and Development
Michael Patterson is the CEO of US Cannabis Pharmaceutical Research and Development LLC (US Cannabis), a privately-held developmental consulting firm which was established in 2014 with the mission of moving society forward through legalized cannabis. US Cannabis develops the legal cannabis/hemp/cbd markets globally across all platforms (education, cultivation, production, dispensing, research and development, management operations and compliance, and physician services). US Cannabis currently works with national, state, and local governments, sovereign nations, and public/private companies in all aspects of the cannabis/hemp/CBD industry throughout the United States and Internationally.
Mr. Patterson is a board member of MGMC-Pharma, an international medical cannabis pharmaceutical corporation with cannabis cultivation, production, and export/distribution licenses in 5 East African Countries (Lesotho, Tanzania, Malawi, Democratic Republic of Congo, Uganda).
Michael is an internationally recognized speaker, subject matter expert in the global cannabis/hemp/cbdindustry, and published author. Michael is a member of the Scientific Advisory Board for Akers Bioscience, a NASDAQ listed biotechnology company, International Cannabis/Hemp/CBD SME for Gerson Lehrman Group (GLG) - an International Investment Consulting Group, and Editorial Board Member for AJEM - American Journal of Endocannabinoid Medicine (the world’s first peer-reviewed printed scientific journal dedicated to the study of endocannabinoid science and medicine).
Mr. Patterson is also a board member for the Medical Cannabis Society, Tourette’s Syndrome Awareness Foundation, Cannabis/Hemp/CBD industry writer for Florida MD Magazine, Orlando Medical News, and licensed Occupational Therapist and Nursing Home Administrator in 4 states. (NJ, NC, VA, FL)